YOUNGMI LEE: Open Payments
NPI 1659317329 · NORTH RICHLAND HILLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 65 payments from 14 companies in 2025. Trend: 2023 $1,018 · 2024 $1,694 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $505 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $243 |
| QOL Medical, LLC | 4 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $104 |
| PFIZER INC. | 3 | $58 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Lilly USA, LLC | 2 | $43 |
| Braintree Laboratories, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: RINVOQ, ENTYVIO, Sucraid, SKYRIZI, XIFAXAN, XELJANZ, CREON, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
